Teva UK Holdco 1 Limited

From Powerbase
Jump to navigation Jump to search

Teva UK Holdco 1 Limited is a company on the UK Companies House register with address or ownership links to Israel. This profile is part of UK companies linked to 'Israel'; see UK companies linked to 'Israel': Methodology for how companies were selected and scored.

Profile

Teva UK Holdco 1 Limited
Trade name
Logo Teva UK Holdco 1 Limited logo.png
Type Private limited Company
Founded 17 Sep 2019
Founder(s)
Defunct
Headquarters Ridings Point, Whistler Drive, Castleford, England, WF10 5HX, England
Industry 21200 - Manufacture of pharmaceutical preparations
Services
Parent Teva Pharmaceutical Industries Limited
Subsidiaries
Revenue
Number of employees
Homepage tevapharm.com
  • Category: P / O (Israeli corporate PSC / parent company; officer(s) with an Israeli correspondence address); connection score 4
  • Company number: 12210932[1]
  • Status: Active
  • Type: Private limited Company
  • Incorporated / registered: 17 Sep 2019
  • SIC: 21200 - Manufacture of pharmaceutical preparations
  • Registered office: Ridings Point, Whistler Drive, Castleford, England, WF10 5HX, England
  • Listing / market cap: Not listed. Parent Teva Pharmaceutical Industries (NYSE: TEVA) ≈ US$48.61bn.[2]

Israel connection:

  • CH PSC: Teva Pharmaceutical Industries Limited (Petah Tikva, Israel), 75%+. One former director had an Israeli correspondence address (CH).

Persons with significant control (CH):[1]

  • Teva Pharmaceutical Industries Limited (active) — address: Basel Street, Petach Tikva, 49131, Israel; legal form Corporate; governing law Israeli Company Regulations; registered at Israel; registration number 520013954; country registered Israel; notified 17 Sep 2019; nature of control: ownership of shares – 75% or more; voting rights – 75% or more; right to appoint or remove directors

Directors (CH; 5 director appointments, 2 current; † = Israel correspondence address, 1 appointments):[1]

Directors (month/year as shown by Companies House; † = Israel correspondence address, an address fact only)
Name Born (month/year) Service †
Stephen Michael Charlesworth February 1967 Apr 2020–present
Dean Michael Cooper September 1972 Sep 2019–present
Doron Herman August 1971 Sep 2019–May 2022 †
Kim Innes August 1968 Sep 2019–Apr 2020
Mr Yaron Aizik Katz December 1968 May 2022–May 2026

Latest accounts (income/expenditure): Full accounts for FY to 31 Dec 2025 (filed 6 Oct 2026; scanned, read by OCR; figures in US$'000): no operating result; interest receivable 78,198 and payable (78,198); amounts written off investments (124,921) (2024: written back 4,048,486); loss for the year US$(124,921)k (2024: profit US$4,048,486k).[3]

Arms trade involvement: None documented. The company's stated business is not in the arms trade.

Supply to the IDF / Israel MOD / Israeli security services: None documented in the sources reviewed.

Activities in the occupied territories: Parent group: Who Profits (information valid to July 2012) lists Teva for exploiting the "Palestinian captive market": easy access, products without Arabic labelling and little generic competition.[4] No OPT activity by the UK company was found.

Links to the Israeli government: None documented in the sources reviewed.

WZO / JNF / Jewish Agency / Keren Hayesod: None found in the sources reviewed.

Controversies (protests, legal cases, export-licence rulings):

See also

Notes

  1. ↑ 1.0 1.1 1.2 Companies House, Teva UK Holdco 1 Limited (12210932): company overview Find and update company information (GOV.UK).
  2. ↑ CompaniesMarketCap, Teva Pharmaceutical Industries (TEVA) – market capitalization companiesmarketcap.com, October 2026.
  3. ↑ Companies House, Teva UK Holdco 1 Limited (12210932): filing history Find and update company information (GOV.UK).
  4. ↑ 4.0 4.1 Who Profits Research Center, Teva Pharmaceutical Industries Who Profits, information valid to 22 July 2012.